Sign in
8-K

Current Report

Alaunos Therapeutics, Inc. Filed Acc 0001193125-15-033807

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d864614d8k.htm…